Article
Mesenchymal stem cells preserve their stem cell traits after exposure to antimetabolite chemotherapy
13 Aug 2019
Abstract excerpt
BACKGROUND: Mesenchymal stem cells (MSCs) participate in the regeneration of tissue lesions induced by antimetabolite chemotherapy; however, the influence of this class of anti-cancer compounds on the stem cells remains largely unknown. METHODS: The survival of MSCs after exposure to 5-fluorouracil (5-FU) and gemcitabine was measured by viability and clonogenic assays. MSC morphology, surface marker expression,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
